Cardiovascular disease-related genes and regulation by diet

Current Atherosclerosis Reports

Volumn 11, Issue 6, 2009, Pages 448-455

  Vanden Heuvel, John P ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; CELL NUCLEUS RECEPTOR; DOCOSAHEXAENOIC ACID; FARNESOID X RECEPTOR; FATTY ACID; ICOSAPENTAENOIC ACID; LEUKOTRIENE; LIGAND; LINOLEIC ACID; LINOLENIC ACID; LIVER X RECEPTOR; OMEGA 3 FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PROSTAGLANDIN; RETINOID X RECEPTOR; THROMBOXANE;

CARDIOVASCULAR DISEASE; DIET; DISEASE SEVERITY; FAT INTAKE; GENE EXPRESSION REGULATION; HUMAN; INCIDENCE; METABOLISM; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION;

CARDIOVASCULAR DISEASES; FATTY ACIDS, OMEGA-3; GENE EXPRESSION REGULATION; HUMANS; ORPHAN NUCLEAR RECEPTORS; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; RETINOID X RECEPTORS; SIGNAL TRANSDUCTION;

EID: 70449502136     PISSN: 15233804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11883-009-0067-x     Document Type: Review

References (49)

1. S. Renaud D. Lanzmann-Petithory 2001 Coronary heart disease: dietary links and pathogenesis Public Health Nutr 4 459 474 10.1079/PHN2001134 1:STN:280:DC%2BD3MngvVajtA%3D%3D 11683541
2. F.B. Hu W.C. Willett 2002 Optimal diets for prevention of coronary heart disease JAMA 288 2569 2578 10.1001/jama.288.20.2569 1:CAS:528: DC%2BD38XptFOgsr8%3D 12444864 (Pubitemid 35386892)
3. A. Erkkila V.D. de Mello U. Riserus D.E. Laaksonen 2008 Dietary fatty acids and cardiovascular disease: an epidemiological approach Prog Lipid Res 47 172 187 10.1016/j.plipres.2008.01.004 18328267
4. D. Mozaffarian W.C. Willett 2007 Trans fatty acids and cardiovascular risk: a unique cardiometabolic imprint? Curr Atheroscler Rep 9 486 493 10.1007/s11883-007-0065-9 1:CAS:528:DC%2BD1cXhtlertbc%3D 18377789
5. R.A. Siddiqui K.A. Harvey G.P. Zaloga 2008 Modulation of enzymatic activities by n-3 polyunsaturated fatty acids to support cardiovascular health J Nutr Biochem 19 417 437 10.1016/j.jnutbio.2007.07.001 1:CAS:528: DC%2BD1cXntlSrt7g%3D 17904342 (Pubitemid 351783409)
6. Nuclear Receptor Nomenclature Committee 1999 A unified nomenclature system for the nuclear receptor superfamily Cell 97 161 163 10.1016/S0092- 8674(00)80726-6
7. S.A. Khan J.P. Vanden Heuvel 2003 Role of nuclear receptors in the regulation of gene expression by dietary fatty acids (review) J Nutr Biochem 14 554 567 10.1016/S0955-2863(03)00098-6 1:CAS:528:DC%2BD3sXotVyjs78%3D 14559106 (Pubitemid 37239008)
8. A. Zhao J. Yu J.L. Lew, et al. 2004 Polyunsaturated fatty acids are FXR ligands and differentially regulate expression of FXR targets DNA Cell Biol 23 519 526 10.1089/1044549041562267 1:CAS:528:DC%2BD2cXmt1Wqtbk%3D 15307955 (Pubitemid 39050558)
9. K. Nagao T. Yanagita 2008 Bioactive lipids in metabolic syndrome Prog Lipid Res 47 127 146 1:CAS:528:DC%2BD1cXislKnsLg%3D 18177744
10. G.A. Francis E. Fayard F. Picard J. Auwerx 2003 Nuclear receptors and the control of metabolism Annu Rev Physiol 65 261 311 10.1146/annurev.physiol.65. 092101.142528 1:CAS:528:DC%2BD3sXjt1Glt7Y%3D 12518001 (Pubitemid 38249155)
11. J.P. Vanden Heuvel J.T. Thompson S.R. Frame P.J. Gillies 2006 Differential activation of nuclear receptors by perfluorinated fatty acid analogs and natural fatty acids: a comparison of human, mouse, and rat peroxisome proliferator-activated receptoralpha, -beta, and -gamma, liver X receptor-beta, and retinoid X receptor-alpha Toxicol Sci 92 476 489 10.1093/toxsci/kfl014 (Pubitemid 44018964)
12. S.Y. Moya-Camarena J.P. Vanden Heuvel S.G. Blanchard, et al. 1999 Conjugated linoleic acid is a potent naturally occurring ligand and activator of PPARalpha J Lipid Res 40 1426 1433 1:CAS:528:DyaK1MXlt1Clsbs%3D 10428978
13. S.Y. Moya-Camarena J.P. Vanden Heuvel M.A. Belury 1999 Conjugated linoleic acid activates peroxisome proliferatoractivated receptor alpha and beta subtypes but does not induce hepatic peroxisome proliferation in Sprague-Dawley rats Biochim Biophys Acta 1436 331 342 1:CAS:528:DyaK1MXovFygsw%3D%3D 9989264
14. O. Ziouzenkova S. Perrey L. Asatryan, et al. 2003 Lipolysis of triglyceride-rich lipoproteins generates PPAR ligands: evidence for an antiinflammatory role for lipoprotein lipase Proc Natl Acad Sci U S A 100 2730 2735 10.1073/pnas.0538015100 1:CAS:528:DC%2BD3sXitVait7w%3D 12606719 (Pubitemid 36297567)
15. A. Chawla C.H. Lee Y. Barak, et al. 2003 PPARdelta is a very low-density lipoprotein sensor in macrophages Proc Natl Acad Sci U S A 100 1268 1273 10.1073/pnas.0337331100 1:CAS:528:DC%2BD3sXhtF2gtbc%3D 12540828 (Pubitemid 36183991)
16. L.A. Cowart S. Wei M.H. Hsu, et al. 2002 The CYP4A isoforms hydroxylate epoxyeicosatrienoic acids to form high affinity peroxisome proliferator- activated receptor ligands J Biol Chem 277 35105 35112 10.1074/jbc.M201575200 1:CAS:528:DC%2BD38Xnt1Wgtb4%3D 12124379 (Pubitemid 35056076)
17. G. Krey O. Braissant E. Kalkhoven M. Perroud, et al. 1997 Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay Mol Endocrinol 11 779 791 10.1210/me.11.6.779 1:CAS:528:DyaK2sXjsVSjsLw%3D 9171241 (Pubitemid 27225305)
18. K. Yu W. Bayona C.B. Kallen, et al. 1995 Differential activation of peroxisome proliferator-activated receptors by eicosanoids J Biol Chem 270 23975 23983 10.1074/jbc.270.41.23975 1:CAS:528:DyaK2MXovVSgsbk%3D 7592593
19. T.M. Willson P.J. Brown D.D. Sternbach B.R. Henke 2000 The PPARs: from orphan receptors to drug discovery J Med Chem 43 527 550 10.1021/jm990554g 1:CAS:528:DC%2BD3cXht1Churk%3D 10691680 (Pubitemid 30127149)
20. B.M. Spiegelman 1998 PPAR-gamma: adipogenic regulator and thiazolidinedione receptor Diabetes 47 507 514 10.2337/diabetes.47.4.507 1:CAS:528:DyaK1cXit1Gnsrk%3D 9568680 (Pubitemid 28160438)
21. Y. Barak M.C. Nelson E.S. Ong, et al. 1999 PPAR gamma is required for placental, cardiac, and adipose tissue development Mol Cell 4 585 595 10.1016/S1097-2765(00)80209-9 1:CAS:528:DyaK1MXntFCgsLY%3D 10549290 (Pubitemid 29531138)
22. T.M. Willson W. Wahli 1997 Peroxisome proliferator-activated receptor agonists Curr Opin Chem Biol 1 235 241 10.1016/S1367-5931(97)80015-4 1:STN:280:DyaK1cznsVKgsw%3D%3D 9667857
23. J.M. Peters S.S. Lee W. Li, et al. 2000 Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta) Mol Cell Biol 20 5119 5128 10.1128/MCB.20.14.5119-5128.2000 1:CAS:528:DC%2BD3cXks1Ojs78%3D 10866668 (Pubitemid 30431565)
24. R.P. Brun P. Tontonoz B.M. Forman, et al. 1996 Differential activation of adipogenesis by multiple PPAR isoforms Genes Dev 10 974 984 10.1101/gad.10.8.974 1:CAS:528:DyaK28Xislahurw%3D 8608944
25. J.D. Coleman K.S. Prabhu J.T. Thompson, et al. 2007 The oxidative stress mediator 4-hydroxynonenal is an intracellular agonist of the nuclear receptor peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) Free Radic Biol Med 42 1155 1164 10.1016/j.freeradbiomed.2007.01.003 1:CAS:528:DC%2BD2sXjsVGhtLc%3D 17382197 (Pubitemid 46428510)
26. S. Rocchi J. Auwerx 1999 Peroxisome proliferator-activated receptor-gamma: a versatile metabolic regulator Ann Med 31 342 351 1:CAS:528:DC%2BD3cXivVaisQ%3D%3D 10574507
27. K. Schoonjans B. Staels J. Auwerx 1996 The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation Biochim Biophys Acta 1302 93 109 1:STN:280:DyaK28zhtlygsA%3D%3D 8695669
28. P. Tontonoz E. Hu R.A. Graves, et al. 1994 mPpar gamma 2: tissue-specific regulator of an adipocyte enhancer Genes Dev 8 1224 1234 10.1101/gad.8.10.1224 1:CAS:528:DyaK2cXlsFSgsbc%3D 7926726
29. P. Tontonoz L. Nagy J.G. Alvarez, et al. 1998 PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL Cell 93 241 252 10.1016/S0092-8674(00)81575-5 1:CAS:528:DyaK1cXivVygu70%3D 9568716 (Pubitemid 28180857)
30. B. Zhang J. Berger E. Hu, et al. 1996 Negative regulation of peroxisome proliferator-activated receptor-gamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor-alpha Mol Endocrinol 10 1457 1466 10.1210/me.10.11.1457 1:CAS:528:DyaK28XmvFSitLs%3D 8923470 (Pubitemid 26423234)
31. M. Ricote J.T. Huang J.S. Welch C.K. Glass 1999 The peroxisome proliferator-activated receptor(PPARgamma) as a regulator of monocyte/macrophage function J Leukoc Biol 66 733 739 1:CAS:528:DyaK1MXnsVanu78%3D 10577502
32. J.M. Lehmann J.M. Lenhard B.B. Oliver, et al. 1997 Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal antiinflammatory drugs J Biol Chem 272 3406 3410 10.1074/jbc.272.6.3406 1:CAS:528:DyaK2sXhtFeltLc%3D 9013583 (Pubitemid 27066837)
33. A.M. de Urquiza S. Liu M. Sjoberg, et al. 2000 Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain Science 290 2140 2144 10.1126/science.290.5499.2140 11118147 (Pubitemid 32001593)
34. J. Lengqvist A.M. De Urquiza A.C. Bergman, et al. 2004 Polyunsaturated fatty acids including docosahexaenoic and arachidonic acid bind to the retinoid X receptor alpha ligand binding domain Mol Cell Proteomics 3 692 703 10.1074/mcp.M400003-MCP200 1:CAS:528:DC%2BD2cXlvFens7k%3D 15073272 (Pubitemid 39077000)
35. P.K. Lemotte S. Keidel C.M. Apfel 1996 Phytanic acid is a retinoid X receptor ligand Eur J Biochem 236 328 333 10.1111/j.1432-1033.1996.00328.x 1:STN:280:DyaK287osV2itg%3D%3D 8617282
36. T. Claudel M.D. Leibowitz C. Fievet, et al. 2001 Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor Proc Natl Acad Sci U S A 98 2610 2615 10.1073/pnas.041609298 1:CAS:528:DC%2BD3MXhslKmsLc%3D 11226287 (Pubitemid 32209530)
37. P. Kastner J.M. Grondona M. Mark, et al. 1994 Genetic analysis of RXR alpha developmental function: convergence of RXR and RAR signaling pathways in heart and eye morphogenesis Cell 78 987 1003 10.1016/0092-8674(94)90274-7 1:CAS:528:DyaK2cXmt1Oiur8%3D 7923367
38. J. Ou H. Tu B. Shan, et al. 2001 Unsaturated fatty acids inhibit transcription of the sterol regulatory element-binding protein-1c (SREBP-1c) gene by antagonizing ligand-dependent activation of the LXR Proc Natl Acad Sci U S A 98 6027 6032 10.1073/pnas.111138698 1:CAS:528:DC%2BD3MXktVWks7w%3D 11371634 (Pubitemid 32488187)
39. A. Pawar D. Botolin D.J. Mangelsdorf D.B. Jump 2003 The role of liver X receptor-alpha in the fatty acid regulation of hepatic gene expression J Biol Chem 278 40736 40743 10.1074/jbc.M307973200 1:CAS:528:DC%2BD3sXotFWgsL4%3D 12917410 (Pubitemid 37280889)
40. K.S. Miyata S.E. McCaw H.V. Patel, et al. 1996 The orphan nuclear hormone receptor LXR alpha interacts with the peroxisome proliferator-activated receptor and inhibits peroxisome proliferator signaling J Biol Chem 271 9189 9192 10.1074/jbc.271.48.30647 1:CAS:528:DyaK28XisFSmtrs%3D 8621574 (Pubitemid 26404080)
41. B.A. Laffitte J.J. Repa S.B. Joseph, et al. 2001 LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes Proc Natl Acad Sci U S A 98 507 512 10.1073/pnas.021488798 1:CAS:528:DC%2BD3MXnslKhtw%3D%3D 11149950 (Pubitemid 32105072)
42. E.G. Lund J.G. Menke C.P. Sparrow 2003 Liver X receptor agonists as potential therapeutic agents for dyslipidemia and atherosclerosis Arterioscler Thromb Vasc Biol 23 1169 1177 10.1161/01.ATV.0000056743.42348.59 1:CAS:528:DC%2BD3sXltVGkur8%3D 12615685 (Pubitemid 36873813)
43. S.B. Joseph E. McKilligin L. Pei, et al. 2002 Synthetic LXR ligand inhibits the development of atherosclerosis in mice Proc Natl Acad Sci U S A 99 7604 7609 10.1073/pnas.112059299 1:CAS:528:DC%2BD38XktlCrsr8%3D 12032330 (Pubitemid 34568738)
44. A. Chawla Y. Barak L. Nagy, et al. 2001 PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation Nat Med 7 48 52 10.1038/83336 1:CAS:528:DC%2BD3MXmvV2nuw%3D%3D 11135615 (Pubitemid 32095641)
45. D.J. Peet S.D. Turley W. Ma, et al. 1998 Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha Cell 93 693 704 10.1016/S0092-8674(00)81432-4 1:CAS:528:DyaK1cXjsl2ksb4%3D 9630215 (Pubitemid 28257577)
46. S. Alberti G. Schuster P. Parini, et al. 2001 Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXRbeta-deficient mice J Clin Invest 107 565 573 10.1172/JCI9794 1:CAS:528:DC%2BD3MXhs12ns7s%3D 11238557
47. M.J. Evans P.E. Mahaney L. Borges-Marcucci, et al. 2009 A synthetic farnesoid X receptor (FXR) agonist promotes cholesterol lowering in models of dyslipidemia Am J Physiol Gastrointest Liver Physiol 296 G543 G552 10.1152/ajpgi.90585.2008 1:CAS:528:DC%2BD1MXjtFGrtbo%3D 19136377
48. A. Mencarelli B. Renga E. Distrutti S. Fiorucci 2009 Antiatherosclerotic effect of farnesoid X receptor Am J Physiol Heart Circ Physiol 296 H272 H281 10.1152/ajpheart.01075.2008 1:CAS:528:DC%2BD1MXitVejsrs%3D 19028791
49. D. Bishop-Bailey 2004 FXR as a novel therapeutic target for vascular disease Drug News Perspect 17 499 504 10.1358/dnp.2004.17.8.863693 1:CAS:528:DC%2BD2MXhs1Kiuw%3D%3D 15605109 (Pubitemid 39642725)